tibenelast has been researched along with Asthma in 2 studies
*Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peyton, AL; Ziege, EA | 1 |
| Bertsch, B; Esterman, M; Ho, PP; Panetta, JA | 1 |
2 other study(ies) available for tibenelast and Asthma
| Article | Year |
|---|---|
Determination of a potential antiasthmatic compound, tibenelast, and its application to phase I clinical trials.
Topics: Asthma; Blood Proteins; Chromatography, High Pressure Liquid; Drug Evaluation; Humans; Indicators and Reagents; Male; Solutions; Thiophenes | 1990 |
Tibenelast, 5,6-diethoxybenzo(B)thiophene-2-carboxylic acid, sodium salt (LY186655), is an orally active anti-asthma compound in the guinea pig.
Topics: Administration, Oral; Airway Resistance; Aminophylline; Anaphylaxis; Animals; Asthma; Bronchodilator Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Epinephrine; Female; Guinea Pigs; Injections, Intravenous; Lung Compliance; Male; Molecular Structure; Thiophenes | 1990 |